Mechanistically, Akt1 directly promotes protein translation, in part by inhibiting GSK3β activity, which negatively regulates eukaryotic translation initiation factor 2B and thereby represses cardiac hypertrophy [30]. The gene discussed is AKT1; the disease is cardiac hypertrophy.